ID

12963

Beschreibung

Weekly Gemcitabine, Epirubicin, and Docetaxel in Locally Advanced or Inflammatory Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00193050

Link

https://clinicaltrials.gov/show/NCT00193050

Stichworte

  1. 07.01.16 07.01.16 -
Hochgeladen am

7. Januar 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :


Keine Kommentare

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Breast Cancer NCT00193050

Eligibility Breast Cancer NCT00193050

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
adenocarcinoma of the breast confirmed by biopsy
Beschreibung

biopsy adenocarcinoma

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0005558
UMLS CUI [1,2]
C0858252
female patients >18 years of age
Beschreibung

age, gender

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0079399
normal cardiac function
Beschreibung

cardiac function

Datentyp

boolean

Alias
UMLS CUI [1]
C0232164
ability to perform activities of daily living with minimal assistance
Beschreibung

performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1518965
chemotherapy naïve or have received prior chemotherapy > 5 years ago
Beschreibung

chemotherapy

Datentyp

boolean

Alias
UMLS CUI [1]
C0392920
adequate bone marrow, liver and kidney function
Beschreibung

bone marrow, liver and kidney function

Datentyp

boolean

Alias
UMLS CUI [1]
C0232741
UMLS CUI [2]
C0005953
UMLS CUI [3]
C0232804
be informed of the investigational nature of this study
Beschreibung

informed consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
sign an informed consent form
Beschreibung

informed consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
sentinel lymph node and/or axillary dissection prior to enrollment
Beschreibung

sentinel lymph node, axillary dissection

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0024203
UMLS CUI [1,2]
C1522495
UMLS CUI [2]
C0193867
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
life expectancy of < than 6 months
Beschreibung

life expectancy

Datentyp

boolean

Alias
UMLS CUI [1]
C0023671
history of significant heart disease
Beschreibung

heart disease

Datentyp

boolean

Alias
UMLS CUI [1]
C0018799
prior chemotherapy or hormonal therapy
Beschreibung

chemotherapy, hormone therapy

Datentyp

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2]
C0279025
concurrent trastuzumab therapy
Beschreibung

trastuzumab

Datentyp

boolean

Alias
UMLS CUI [1]
C0338204
history of significant psychiatric disorders
Beschreibung

comorbidity

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0004936
history of active uncontrolled infection
Beschreibung

infection

Datentyp

boolean

Alias
UMLS CUI [1]
C0009450
please note: there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons. if you do qualify, study personnel will explain the trial in detail and answer any questions you may have.
Beschreibung

additional inclusion/exclusion criteria

Datentyp

boolean

Ähnliche Modelle

Eligibility Breast Cancer NCT00193050

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
biopsy adenocarcinoma
Item
adenocarcinoma of the breast confirmed by biopsy
boolean
C0005558 (UMLS CUI [1,1])
C0858252 (UMLS CUI [1,2])
age, gender
Item
female patients >18 years of age
boolean
C0001779 (UMLS CUI [1])
C0079399 (UMLS CUI [2])
cardiac function
Item
normal cardiac function
boolean
C0232164 (UMLS CUI [1])
performance status
Item
ability to perform activities of daily living with minimal assistance
boolean
C1518965 (UMLS CUI [1])
chemotherapy
Item
chemotherapy naïve or have received prior chemotherapy > 5 years ago
boolean
C0392920 (UMLS CUI [1])
bone marrow, liver and kidney function
Item
adequate bone marrow, liver and kidney function
boolean
C0232741 (UMLS CUI [1])
C0005953 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
informed consent
Item
be informed of the investigational nature of this study
boolean
C0021430 (UMLS CUI [1])
informed consent
Item
sign an informed consent form
boolean
C0021430 (UMLS CUI [1])
sentinel lymph node, axillary dissection
Item
sentinel lymph node and/or axillary dissection prior to enrollment
boolean
C0024203 (UMLS CUI [1,1])
C1522495 (UMLS CUI [1,2])
C0193867 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
life expectancy
Item
life expectancy of < than 6 months
boolean
C0023671 (UMLS CUI [1])
heart disease
Item
history of significant heart disease
boolean
C0018799 (UMLS CUI [1])
chemotherapy, hormone therapy
Item
prior chemotherapy or hormonal therapy
boolean
C0392920 (UMLS CUI [1])
C0279025 (UMLS CUI [2])
trastuzumab
Item
concurrent trastuzumab therapy
boolean
C0338204 (UMLS CUI [1])
comorbidity
Item
history of significant psychiatric disorders
boolean
C0009488 (UMLS CUI [1,1])
C0004936 (UMLS CUI [1,2])
infection
Item
history of active uncontrolled infection
boolean
C0009450 (UMLS CUI [1])
additional inclusion/exclusion criteria
Item
please note: there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons. if you do qualify, study personnel will explain the trial in detail and answer any questions you may have.
boolean

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video